Home Does Homocysteine Cause Hypertension?
Article
Licensed
Unlicensed Requires Authentication

Does Homocysteine Cause Hypertension?

  • Coen D. A. Stehouwer and Coen van Guldener
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 41 Issue 11

Abstract

Several studies, some population-based, have plasma homocysteine levels linked to blood pressure, especially systolic pressure. In one large and carefully conducted epidemiological study, each 5 μmol/l increase in plasma homocysteine was associated with an increase in systolic and diastolic blood pressure of 0.7/0.5 mmHg in men and 1.2/0.7 mmHg in women, which was independent of renal function and B vitamin status. In addition, observations that homocysteine-lowering therapies with folic acid-based treatments have been followed by decreases in blood pressure raise the possibility that the link between homocysteine and blood pressure is causal, which is important since homocysteine levels can easily be lowered by folic acid-based regimens. Mechanisms that could explain the relationship between homocysteine and blood pressure include homocysteine-induced arteriolar constriction, renal dysfunction and increased sodium reabsorption, and increased arterial stiffness. However, there is only circumstantial evidence that these mechanisms are operative in humans. In addition, confounding by subtle renal dysfunction or by unmeasured dietary and lifestyle factors cannot be excluded as an explanation for the association between homocysteine and blood pressure. At present, therefore, the hypothesis that homocysteine increases blood pressure must be considered unproven. Ongoing large intervention studies with homocysteine-lowering vitamins may show whether blood pressure is indeed lowered by these vitamins, whether the blood pressure decrease, if any, is explained by the decrease in homocysteine levels, and whether a vitamin treatment-associated decrease in cardiovascular morbidity, if any, is explained by the decrease in blood pressure.

:
Published Online: 2005-06-01
Published in Print: 2003-11-17

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Where Are We Standing in Homocysteine Research?
  2. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations
  3. Hyperhomocysteinaemia as a Risk Factor for Venous Thrombosis: An Update of the Current Evidence
  4. Does Homocysteine Cause Hypertension?
  5. Homocysteine Metabolism in Renal Disease
  6. Hyperhomocysteinemia and B-Vitamin Deficiencies in Infants and Children
  7. The Role of Genetic Factors in the Development of Hyperhomocysteinemia
  8. New Basis of the Neurotrophic Action of Vitamin B12
  9. Hyperhomocysteinemia and Immune Activation
  10. Interactions of Homocysteine, Nitric Oxide, Folate and Radicals in the Progressively Damaged Endothelium
  11. Influence of Hyperhomocysteinemia on the Cellular Redox State – Impact on Homocysteine-Induced Endothelial Dysfunction
  12. Homocysteine-Thiolactone and S-Nitroso-Homocysteine Mediate Incorporation of Homocysteine into Protein in Humans
  13. Association of Asymmetric Dimethylarginine and Endothelial Dysfunction
  14. Genetic Determinants of Folate and Vitamin B12 Metabolism: A Common Pathway in Neural Tube Defect and Down Syndrome?
  15. Functional Vitamin B12 Deficiency and Determination of Holotranscobalamin in Populations at Risk
  16. Holotranscobalamin as a Predictor of Vitamin B12 Status
  17. Hyperhomocysteinemia and B-Vitamin Status after Discontinuation of Oral Anticoagulation Therapy in Patients with a History of Venous Thromboembolism
  18. Measurement of Carotid Plaque and Effect of Vitamin Therapy for Total Homocysteine
  19. Folate Improves Endothelial Function in Patients with Coronary Heart Disease
  20. The Impact of Hyperhomocysteinemia as a Cardiovascular Risk Factor in the Prediction of Coronary Heart Disease
  21. Homocysteine Increases during Endurance Exercise
  22. Comparison of the Influence of Volume-Oriented Training and High-Intensity Interval Training on Serum Homocysteine and Its Cofactors in Young, Healthy Swimmers
  23. Analysis of the Transcobalamin II 776C>G (259P>R) Single Nucleotide Polymorphism by Denaturing HPLC in Healthy Elderly: Associations with Cobalamin, Homocysteine and Holo-Transcobalamin II
  24. Meetings and Awards
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.216/html
Scroll to top button